What you stated here is factual. The concern that I have is that there are no concerete plans for phase 3 for either product. It is good that SYN plans further meetings with the FDA however when are they scheduled or are things just hanging out there hoping for further meetings?
Also further proof of from phase 2 studies are nice but what further proof is needed? There isn't an intelligent person out there that doesn't know that SYN's two lead compounds work and work well.
Another concern is that there are other companies that are developing compounds that deal with the same medical problems. One of them is Pfizer developing a compound that treats C.Diff. I believe that the Pfizer compound is a vaccine. Perhaps someone on this board can clarify that.
News 
Market Data 
Discover 
